Arthrogryposis Multiplex Congenita Overview

Save information for later
Sign Up

Learn About Arthrogryposis Multiplex Congenita

What is the definition of Arthrogryposis Multiplex Congenita?
Arthrogryposis multiplex congenita (AMC) refers to the development of multiple joint contractures affecting two or more areas of the body prior to birth. A contracture occurs when a joint becomes permanently fixed in a bent or straightened position, which can impact the function and range of motion of the joint and may lead to muscle atrophy. AMC is not a specific diagnosis, but rather a physical symptom that can be associated with many different medical conditions. It is suspected that AMC is related to decreased fetal movement during development which can have a variety of different causes, including environmental factors (i.e. maternal illness, limited space), single gene changes (autosomal dominant, autosomal recessive, X-linked), chromosomal abnormalities and various syndromes.
What are the alternative names for Arthrogryposis Multiplex Congenita?
  • Arthrogryposis multiplex congenita
  • Arthrogryposis
  • Congenital arthromyodysplasia
  • Congenital multiple arthrogryposis
  • Fibrous ankylosis of multiple joints
  • Guerin-Stern syndrome
  • Guérin-Stern syndrome
  • Myodystrophia fetalis deformans
  • Otto syndrome
  • Rocher-Sheldon syndrome
  • Rossi syndrome
Who are the top Arthrogryposis Multiplex Congenita Local Doctors?
Experienced in Arthrogryposis Multiplex Congenita
Dr. Jonathan E. Campbell
Orthopedics
Experienced in Arthrogryposis Multiplex Congenita
Dr. Jonathan E. Campbell
Orthopedics

Froedtert Andthe Medical College Of Wisconsin Community Physicians Inc

4805 S Moorland Rd, 
New Berlin, WI 
 (43.2 mi)
262-798-7200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jonathan Campbell is an Orthopedics provider in New Berlin, Wisconsin. Dr. Campbell and is rated as an Experienced provider by MediFind in the treatment of Arthrogryposis Multiplex Congenita. His top areas of expertise are Osteoarthritis, Congenital Contractures, Arthrogryposis Multiplex Congenita, Clubfoot, and Hip Replacement. Dr. Campbell is currently accepting new patients.

Distinguished in Arthrogryposis Multiplex Congenita
Dr. Philip F. Giampietro
Pediatrics | Medical Genetics
Distinguished in Arthrogryposis Multiplex Congenita
Dr. Philip F. Giampietro
Pediatrics | Medical Genetics
1500 Highland Ave, 
Madison, WI 
 (43.1 mi)
608-829-5485
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Philip Giampietro is a Pediatrics specialist and a Medical Genetics provider in Madison, Wisconsin. Dr. Giampietro and is rated as a Distinguished provider by MediFind in the treatment of Arthrogryposis Multiplex Congenita. His top areas of expertise are Arthrogryposis Multiplex Congenita, Congenital Contractures, VACTERL Association, and FG Syndrome. Dr. Giampietro is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Arthrogryposis Multiplex Congenita
Dr. David J. Colvin
Family Medicine
Experienced in Arthrogryposis Multiplex Congenita
Dr. David J. Colvin
Family Medicine

Curana Health Of Wisconsin Inc

1366 E Sumner St, Suite 1002, 
Hartford, WI 
 (18.6 mi)
337-408-0805
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Colvin is a Family Medicine provider in Hartford, Wisconsin. Dr. Colvin and is rated as an Experienced provider by MediFind in the treatment of Arthrogryposis Multiplex Congenita. His top areas of expertise are COVID-19, Muscle Atrophy, Swallowing Difficulty, and Painful Swallowing. Dr. Colvin is currently accepting new patients.

View All Doctors
What are the latest Arthrogryposis Multiplex Congenita Clinical Trials?
Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Enrollment Status: Recruiting
Publish Date: January 17, 2025

Summary: The purpose of this study is to characterize oxidative stress and the Nrf2 antioxidant response in early stages of Autosomal Dominant Polycystic Kidney Disease (ADPKD), while identifying candidate biomarkers.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Prospective Observational Study of Foam Sclerotherapy for the Treatment of Symptomatic Kidney or Liver Cysts in Patients with Autosomal Dominant Polycystic Kidney and Liver Disease.
A Prospective Observational Study of Foam Sclerotherapy for the Treatment of Symptomatic Kidney or Liver Cysts in Patients with Autosomal Dominant Polycystic Kidney and Liver Disease.
Enrollment Status: Recruiting
Publish Date: December 27, 2024

Summary: An observational prospective study to determine the impact of foam sclerotherapy of large, dominant kidney/liver cysts on quality of life outcomes and kidney/liver cyst volumes at up to 12 months of follow-up in patients with autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD).

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center